JPMorgan Chase & Co. Reaffirms Overweight Rating for Netflix …

JPMorgan Chase & Co. Reaffirms Overweight Rating For Netflix …

2 weeks from now

Oct 8, 2024  · JPMorgan Chase & Co. reaffirmed an "overweight" rating and set a $750.00 price objective on shares of Netflix in a report on Tuesday.

marketbeat.com

JPMorgan Chase & Co. Reiterates Overweight Rating For

2 weeks from now

Dec 17, 2024  · JPMorgan Chase & Co. reaffirmed an "overweight" rating and set a $75.00 target price (down previously from $80.00) on shares of Centene in a research note on Tuesday.

marketbeat.com

JPMorgan Stock Maintains Overweight Rating With Upbeat Revenue …

2 weeks from now

Jun 13, 2024  · On Thursday, Piper Sandler sustained its Overweight rating and $220.00 price target for JPMorgan Chase & Co. (NYSE:NYSE: JPM), following an encouraging update on …

investing.com

JPMorgan Chase & Co. Buys 307,906 Shares Of Sprout Social

2 weeks from now

3 days ago  · JPMorgan Chase & Co. raised its stake in Sprout Social, Inc. (NASDAQ:SPT - Free Report) by 324.0% during the third quarter, according to the company in its most recent Form …

marketbeat.com

JPMorgan Chase & Co. Reaffirms "Overweight" Rating For

2 weeks from now

Dec 11, 2024  · JPMorgan Chase & Co. reiterated an "overweight" rating and set a GBX 350 ($4.47) target price on shares of Barclays in a research report on Wednesday.

marketbeat.com

JPMorgan Chase : Barclays Adjusts JPMorgan Chase & Co PT To …

2 weeks from now

-- JPMorgan Chase & Co has an average rating of Outperform and price targets ranging from $80 to $164, according to analysts polled by Capital IQ. Price: 125.63, Change: -1.44, Percent …

marketscreener.com

Relx's (REL) "Overweight" Rating Reiterated At JPMorgan Chase

2 weeks from now

Jan 7, 2025  · JPMorgan Chase & Co. reaffirmed an "overweight" rating and issued a GBX 4,550 ($56.92) target price on shares of Relx in a research note on Tuesday.

marketbeat.com

JPMorgan Sustains Overweight Rating On Merck, Cites Positive Trial ...

2 weeks from now

Nov 19, 2024  · On Tuesday, JPMorgan reaffirmed its Overweight rating and $145.00 stock price target for Merck (NS: PROR) & Co Inc (NYSE:MRK), following the pharmaceutical company's …

investing.com

JPMorgan Chase & Co. Reaffirms "Neutral" Rating For Ardent …

2 weeks from now

Dec 17, 2024  · JPMorgan Chase & Co. reissued a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday.

marketbeat.com

JPMorgan Chase & Co. Has $12.60 Million Position In National …

2 weeks from now

4 days ago  · JPMorgan Chase & Co. trimmed its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 5.5% in the third quarter, according to its most recent disclosure …

marketbeat.com

JPMorgan Chase & Co. Increases Position In Virtu Financial, Inc ...

2 weeks from now

3 days ago  · JPMorgan Chase & Co. raised its position in shares of Virtu Financial, Inc. (NASDAQ:VIRT - Free Report) by 48.6% in the third quarter, according to the company in its …

marketbeat.com

JPMorgan Chase & Co. Purchases 777,568 Shares Of Amneal

2 weeks from now

3 days ago  · JPMorgan Chase & Co. raised its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 149.7% during the 3rd quarter, according to the company …

marketbeat.com

JPMorgan Chase & Co. Sells 11,955 Shares Of OSI Systems

2 weeks from now

3 days ago  · The firm owned 72,392 shares of the technology company's stock after selling 11,955 shares during the period. JPMorgan Chase & Co. owned approximately 0.43% of OSI …

marketbeat.com